Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07398976 · ClinicalTrials.gov registry record · NA
Sex Differences in E-Cigarette Perception
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07398976 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 60 participants.
The verdict
NCT07398976, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study examines differences between males and females in the appeal and addiction potential of menthol flavored e-cigarettes with and without nicotine.
Interventions
- OTHER Nicotine Level 1 (0mg/ml)
- OTHER Nicotine Level 2 (36mg/ml)
- OTHER Nicotine Level 3 (59mg/ml)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07398976
The ClinicalTrials.gov registry entry for NCT07398976 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine Level 1 (0mg/ml) is the first listed.
NCT07398976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07398976 about?
NCT07398976 is a clinical study titled "Sex Differences in E-Cigarette Perception". This study examines differences between males and females in the appeal and addiction potential of menthol flavored e-cigarettes with and without nicotine.
What is the current status of trial NCT07398976?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-06-15. Estimated completion is 2027-04-01.
What interventions are being tested in trial NCT07398976?
The interventions under investigation include: Nicotine Level 1 (0mg/ml) (OTHER), Nicotine Level 2 (36mg/ml) (OTHER), Nicotine Level 3 (59mg/ml) (OTHER).
Who is sponsoring clinical trial NCT07398976?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.